Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan

• Published in: Epidemiology and infection Vol. 152; p. e24
• Main Authors: Yamayoshi, Seiya, Nagai, Etsuko, Mitamura, Keiko, Hagihara, Masao, Kobayashi, Ryo, Takahashi, Satoshi, Shibata, Akimichi, Uwamino, Yoshifumi, Hasegawa, Naoki, Iqbal, Asef, Kamimaki, Isamu, Iwatsuki-Horimoto, Kiyoko, Nagamura-Inoue, Tokiko, Kawaoka, Yoshihiro
• Format: Journal Article
• Language: English
• Published: Cambridge, UK Cambridge University Press 23.01.2024
• Subjects: Antibodies; Coronaviruses; COVID-19; COVID-19 vaccines; Health facilities; Immunization; Infections; Metropolitan areas; N protein; Pandemics; Proteins; Respiratory diseases; Serology; Severe acute respiratory syndrome coronavirus 2; Short Paper; Vaccination; Viral diseases; Japan; COVID-19; seroprevalence; SARS-CoV-2; N protein; Japan

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 in China and rapidly spread worldwide, leading to a pandemic. The threat of SARS-CoV-2 is subsiding as most people have acquired sufficient antibodies through vaccination and/or infection to prevent severe COVID-19. After t...